Skip to main content

Table 1 Patient characteristics according to diagnoses years

From: Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea

  2020
(Feb–Jun)
(n = 169)
2017–19
(Feb–Jun)
(n = 443)
P value
Age at diagnosis, mean ± SD 69.4 ± 11.1 69.0 ± 10.6 0.637
Sex, Female 53 (31.4%) 135 (30.5%) 0.832
Performance, ECOG 0–2, (%) 91.7% 93.2% 0.686
Smoking, never smoker, (%) 34.4% 29.3% 0.443
Subtype    0.807
 NSCLC 146 (86.4%) 386 (87.1%)  
 SCLC 23 (13.6%) 57 (12.9%)  
Stage of NSCLC    0.015*
 IA–IB 31 (21.2%) 98 (25.4%)  
 IIA–IIB 6 (4.1%) 47 (12.2%)  
 IIIA–IIIC 28 (19.2%) 76 (19.7%)  
 IVA–IVB 81 (55.5%) 165 (42.7%)  
Stage of SCLC    0.042
 Limited disease 11 (47.8%) 14 (24.6%)  
 Extensive disease 12 (52.2%) 43 (75.4%)  
  1. SD standard deviation, ECOG Eastern Cooperative Oncology Group, NSCLC non-small cell lung cancer, SCLC small cell lung cancer
  2. *Statistical significance was tested by the linear by linear association
\